Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
30
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Thomas Monica R. | General Counsel | 11 | $0 | $24.9K | 2024-09-18 |
| Umstead John W. V | Chief Financial Officer | 18 | $0 | $62.4K | 2024-09-18 |
| Sharpless Norman | Director | 8 | $0 | $0 | 2024-09-18 |
| Lee Jacks | Director | 10 | $0 | $0 | 2024-09-18 |
| Perry Andrew | Chief Commercial Officer | 20 | $0 | $55.4K | 2024-09-18 |
| Bailey John E. (Jack) Jr. | President and CEO | 28 | $102.4K | $922.5K | 2024-09-18 |
| Avagliano Mark | Chief Business Officer | 24 | $0 | $73.6K | 2024-09-18 |
| Schwalm Cynthia | Director | 17 | $26.2K | $0 | 2024-09-18 |
| Malik Rajesh | Chief Medical Officer | 126 | $0 | $3.94M | 2024-09-18 |
| Nicholson Garry A | Director | 17 | $0 | $0 | 2024-09-18 |
| Secor Alicia | Director | 12 | $0 | $0 | 2024-09-18 |
| MURDOCK TERRY L | SVP of Development Operations | 45 | $0 | $936.0K | 2024-09-18 |
| MUIR GLENN P | Director | 22 | $975.0K | $0 | 2024-09-18 |
| Velleca Mark A. | President and CEO | 144 | $0 | $8.88M | 2023-08-08 |
| Hanson James S. | General Counsel | 15 | $65.7K | $28.4K | 2023-01-05 |
| Moses Jennifer K. | VP of Finance & Admin | 68 | $0 | $378.4K | 2023-01-05 |
| Deese Willie A | Director | 7 | $0 | $0 | 2022-06-23 |
| RUDNICK SETH | Director | 40 | $0 | $3.71M | 2021-06-29 |
| Gupta Soma | Chief Commercial Officer | 3 | $0 | $0 | 2021-01-04 |
| ESHELMAN FREDRIC N | Director, 10% Owner | 9 | $9.43M | $0 | 2020-06-11 |
| DEMAREE JOHN | Chief Commercial Officer | 4 | $33.1K | $0 | 2020-02-06 |
| WITTY ANDREW | Director | 3 | $0 | $0 | 2019-06-12 |
| Strum Jay | Chief Scientific Officer | 19 | $0 | $596.0K | 2019-01-02 |
| PHILLIPS BARCLAY A | SVP & Chief Financial Officer | 5 | $0 | $199.6K | 2019-01-02 |
| Reed Douglas MD | 10% Owner | 18 | $2.00M | $40.32M | 2018-05-30 |
| MedImmune Ventures, Inc. | 10% Owner | 9 | $2.25M | $10.60M | 2017-12-15 |
| LEE KENNETH B JR | 10% Owner | 2 | $0 | $0 | 2017-11-30 |
| SHAFFER CHRISTY L | Director | 6 | $0 | $0 | 2017-11-30 |
| Eshelman Ventures, LLC | 10% Owner | 4 | $4.50M | $0 | 2017-05-22 |
| Kolchinsky Peter | Other | 5 | $6.00M | $0 | 2017-05-22 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| MUIR GLENN P | Director | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| MUIR GLENN P | Director | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| MUIR GLENN P | Director | D To issuer deriv | 2024-09-18 | 2024-09-18 | 50,000 | — | $0 | 0 | SEC↗ |
| MUIR GLENN P | Director | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| Perry Andrew | Chief Commercial Officer | D To issuer deriv | 2024-09-18 | 2024-09-18 | 32,100 | — | $0 | 0 | SEC↗ |
| Perry Andrew | Chief Commercial Officer | D To issuer deriv | 2024-09-18 | 2024-09-18 | 67,050 | — | $0 | 0 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | D To issuer deriv | 2024-09-18 | 2024-09-18 | 35,700 | — | $0 | 0 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | D To issuer deriv | 2024-09-18 | 2024-09-18 | 74,500 | — | $0 | 0 | SEC↗ |
| Sharpless Norman | Director | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| Sharpless Norman | Director | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| Umstead John W. V | Chief Financial Officer | D To issuer deriv | 2024-09-18 | 2024-09-18 | 6,000 | — | $0 | 0 | SEC↗ |
| Umstead John W. V | Chief Financial Officer | D To issuer deriv | 2024-09-18 | 2024-09-18 | 74,500 | — | $0 | 0 | SEC↗ |
| Umstead John W. V | Chief Financial Officer | D To issuer deriv | 2024-09-18 | 2024-09-18 | 100,000 | — | $0 | 0 | SEC↗ |
| Lee Jacks | Director | D To issuer deriv | 2024-09-18 | 2024-09-18 | 60,000 | — | $0 | 0 | SEC↗ |
| Lee Jacks | Director | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| Lee Jacks | Director | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| Thomas Monica R. | Chief Legal & People Officer | D To issuer deriv | 2024-09-18 | 2024-09-18 | 55,875 | — | $0 | 0 | SEC↗ |
| Thomas Monica R. | Chief Legal & People Officer | D To issuer deriv | 2024-09-18 | 2024-09-18 | 150,000 | — | $0 | 0 | SEC↗ |
| Avagliano Mark | Chief Business Officer | D To issuer deriv | 2024-09-18 | 2024-09-18 | 89,400 | — | $0 | 0 | SEC↗ |
| Avagliano Mark | Chief Business Officer | D To issuer deriv | 2024-09-18 | 2024-09-18 | 41,100 | — | $0 | 0 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | D To issuer deriv | 2024-09-18 | 2024-09-18 | 161,300 | — | $0 | 0 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | D To issuer deriv | 2024-09-18 | 2024-09-18 | 201,300 | — | $0 | 0 | SEC↗ |
| Nicholson Garry A | Director | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| Nicholson Garry A | Director | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| Nicholson Garry A | Director | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| Secor Alicia | Director | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| Secor Alicia | Director | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| Secor Alicia | Director | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| Flowers Cynthia Louise | Director | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| Flowers Cynthia Louise | Director | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| Flowers Cynthia Louise | Director | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | D To issuer deriv | 2024-09-18 | 2024-09-18 | 74,500 | — | $0 | 0 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | D To issuer deriv | 2024-09-18 | 2024-09-18 | 57,333 | — | $0 | 0 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | D To issuer deriv | 2024-09-18 | 2024-09-18 | 35,700 | — | $0 | 0 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | D To issuer deriv | 2024-09-18 | 2024-09-18 | 36,924 | — | $0 | 0 | SEC↗ |
| MUIR GLENN P | Director | U Tender | 2024-09-18 | 2024-09-18 | 185,358 | — | $0 | 0 | SEC↗ |
| MUIR GLENN P | Director | D To issuer | 2024-09-18 | 2024-09-18 | 20,000 | — | $0 | 185,358 | SEC↗ |
| Perry Andrew | Chief Commercial Officer | U Tender | 2024-09-18 | 2024-09-18 | 14,232 | — | $0 | 0 | SEC↗ |
| Perry Andrew | Chief Commercial Officer | D To issuer | 2024-09-18 | 2024-09-18 | 114,482 | — | $0 | 14,232 | SEC↗ |
| Perry Andrew | Chief Commercial Officer | A Award | 2024-09-18 | 2024-09-18 | 16,100 | — | $0 | 128,714 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | D To issuer | 2024-09-18 | 2024-09-18 | 124,762 | — | $0 | 21,150 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | U Tender | 2024-09-18 | 2024-09-18 | 21,150 | — | $0 | 0 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | A Award | 2024-09-18 | 2024-09-18 | 17,900 | — | $0 | 145,912 | SEC↗ |
| Sharpless Norman | Director | D To issuer | 2024-09-18 | 2024-09-18 | 20,000 | — | $0 | 0 | SEC↗ |
| Umstead John W. V | Chief Financial Officer | U Tender | 2024-09-18 | 2024-09-18 | 19,331 | — | $0 | 0 | SEC↗ |
| Umstead John W. V | Chief Financial Officer | D To issuer | 2024-09-18 | 2024-09-18 | 168,387 | — | $0 | 19,331 | SEC↗ |
| Lee Jacks | Director | D To issuer | 2024-09-18 | 2024-09-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Lee Jacks | Director | U Tender | 2024-09-18 | 2024-09-18 | 10,000 | — | $0 | 0 | SEC↗ |
| Thomas Monica R. | Chief Legal & People Officer | U Tender | 2024-09-18 | 2024-09-18 | 6,674 | — | $0 | 0 | SEC↗ |
| Thomas Monica R. | Chief Legal & People Officer | D To issuer | 2024-09-18 | 2024-09-18 | 138,151 | — | $0 | 6,674 | SEC↗ |
| Avagliano Mark | Chief Business Officer | D To issuer | 2024-09-18 | 2024-09-18 | 236,610 | — | $0 | 26,035 | SEC↗ |
| Avagliano Mark | Chief Business Officer | A Award | 2024-09-18 | 2024-09-18 | 20,600 | — | $0 | 262,645 | SEC↗ |
| Avagliano Mark | Chief Business Officer | U Tender | 2024-09-18 | 2024-09-18 | 26,035 | — | $0 | 0 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | U Tender | 2024-09-18 | 2024-09-18 | 196,287 | — | $0 | 0 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | D To issuer | 2024-09-18 | 2024-09-18 | 534,787 | — | $0 | 196,287 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | A Award | 2024-09-18 | 2024-09-18 | 181,400 | — | $0 | 731,074 | SEC↗ |
| Nicholson Garry A | Director | D To issuer | 2024-09-18 | 2024-09-18 | 20,000 | — | $0 | 14,389 | SEC↗ |
| Nicholson Garry A | Director | U Tender | 2024-09-18 | 2024-09-18 | 14,389 | — | $0 | 0 | SEC↗ |
| Secor Alicia | Director | D To issuer | 2024-09-18 | 2024-09-18 | 20,000 | — | $0 | 10,000 | SEC↗ |
| Secor Alicia | Director | U Tender | 2024-09-18 | 2024-09-18 | 10,000 | — | $0 | 0 | SEC↗ |
| Flowers Cynthia Louise | Director | D To issuer | 2024-09-18 | 2024-09-18 | 20,000 | — | $0 | 15,889 | SEC↗ |
| Flowers Cynthia Louise | Director | U Tender | 2024-09-18 | 2024-09-18 | 15,889 | — | $0 | 0 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | U Tender | 2024-09-18 | 2024-09-18 | 87,450 | — | $0 | 0 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | D To issuer | 2024-09-18 | 2024-09-18 | 89,762 | — | $0 | 87,450 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | A Award | 2024-09-18 | 2024-09-18 | 17,900 | — | $0 | 177,212 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | S Sale | 2024-07-05 | 2024-07-08 | 7,662 | $2.51 | $19.2K | 549,674 | SEC↗ |
| Umstead John W. V | Chief Financial Officer | S Sale | 2024-07-05 | 2024-07-08 | 527 | $2.51 | $1.3K | 187,718 | SEC↗ |
| Avagliano Mark | Chief Business Officer | S Sale | 2024-07-05 | 2024-07-08 | 2,638 | $2.51 | $6.6K | 242,045 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | S Sale | 2024-07-05 | 2024-07-08 | 2,475 | $2.51 | $6.2K | 159,312 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | S Sale | 2024-07-05 | 2024-07-08 | 2,475 | $2.51 | $6.2K | 128,012 | SEC↗ |
| Perry Andrew | Chief Commercial Officer | S Sale | 2024-07-05 | 2024-07-08 | 1,337 | $2.51 | $3.4K | 112,614 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | A Award | 2024-07-01 | 2024-07-03 | 105,000 | — | $0 | 557,336 | SEC↗ |
| Umstead John W. V | Chief Financial Officer | A Award | 2024-07-01 | 2024-07-03 | 35,000 | — | $0 | 188,245 | SEC↗ |
| Avagliano Mark | Chief Business Officer | A Award | 2024-07-01 | 2024-07-03 | 35,000 | — | $0 | 244,683 | SEC↗ |
| Thomas Monica R. | Chief Legal & People Officer | A Award | 2024-07-01 | 2024-07-03 | 35,000 | — | $0 | 144,825 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | A Award | 2024-07-01 | 2024-07-03 | 35,000 | — | $0 | 130,487 | SEC↗ |
| Perry Andrew | Chief Commercial Officer | A Award | 2024-07-01 | 2024-07-03 | 35,000 | — | $0 | 113,951 | SEC↗ |
| Nicholson Garry A | Director | A Award deriv | 2024-06-13 | 2024-06-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Flowers Cynthia Louise | Director | A Award deriv | 2024-06-13 | 2024-06-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Lee Jacks | Director | A Award deriv | 2024-06-13 | 2024-06-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MUIR GLENN P | Director | A Award deriv | 2024-06-13 | 2024-06-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Secor Alicia | Director | A Award deriv | 2024-06-13 | 2024-06-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Sharpless Norman | Director | A Award deriv | 2024-06-13 | 2024-06-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Nicholson Garry A | Director | A Award | 2024-06-13 | 2024-06-14 | 10,000 | — | $0 | 34,389 | SEC↗ |
| Flowers Cynthia Louise | Director | A Award | 2024-06-13 | 2024-06-14 | 10,000 | — | $0 | 35,889 | SEC↗ |
| Lee Jacks | Director | A Award | 2024-06-13 | 2024-06-14 | 10,000 | — | $0 | 20,000 | SEC↗ |
| MUIR GLENN P | Director | A Award | 2024-06-13 | 2024-06-14 | 10,000 | — | $0 | 205,358 | SEC↗ |
| Secor Alicia | Director | A Award | 2024-06-13 | 2024-06-14 | 10,000 | — | $0 | 30,000 | SEC↗ |
| Sharpless Norman | Director | A Award | 2024-06-13 | 2024-06-14 | 10,000 | — | $0 | 20,000 | SEC↗ |
| Thomas Monica R. | Chief Legal & People Officer | S Sale | 2024-05-23 | 2024-05-24 | 5,826 | $4.27 | $24.9K | 109,825 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | S Sale | 2024-05-13 | 2024-05-15 | 37,258 | $4.79 | $178.5K | 452,336 | SEC↗ |
| Avagliano Mark | Chief Business Officer | S Sale | 2024-05-13 | 2024-05-15 | 8,151 | $4.79 | $39.0K | 209,683 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | S Sale | 2024-05-13 | 2024-05-15 | 8,151 | $4.79 | $39.0K | 161,787 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | S Sale | 2024-05-13 | 2024-05-15 | 8,151 | $4.79 | $39.0K | 95,487 | SEC↗ |
| Umstead John W. V | Chief Financial Officer | S Sale | 2024-05-13 | 2024-05-15 | 8,151 | $4.79 | $39.0K | 153,245 | SEC↗ |
| Perry Andrew | Chief Commercial Officer | S Sale | 2024-05-13 | 2024-05-15 | 8,151 | $4.79 | $39.0K | 78,951 | SEC↗ |
| Umstead John W. V | Chief Financial Officer | A Award | 2024-03-20 | 2024-03-22 | 37,500 | — | $0 | 161,396 | SEC↗ |
| Avagliano Mark | Chief Business Officer | A Award | 2024-03-20 | 2024-03-22 | 100,000 | — | $0 | 217,834 | SEC↗ |
| Thomas Monica R. | General Counsel | A Award | 2024-03-20 | 2024-03-22 | 37,500 | — | $0 | 115,651 | SEC↗ |
| Umstead John W. V | Chief Financial Officer | S Sale | 2024-03-18 | 2024-03-20 | 6,547 | $3.02 | $19.8K | 123,896 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | M Exercise deriv | 2024-02-12 | 2024-02-13 | 28,600 | — | $0 | 0 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | S Sale | 2024-02-12 | 2024-02-13 | 28,600 | $4.62 | $132.1K | 169,938 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | M Exercise | 2024-02-12 | 2024-02-13 | 28,600 | $0.30 | $8.6K | 198,538 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | S Sale | 2024-01-04 | 2024-01-08 | 721 | $2.94 | $2.1K | 103,638 | SEC↗ |
| Avagliano Mark | Chief Business Officer | S Sale | 2024-01-04 | 2024-01-08 | 721 | $2.94 | $2.1K | 117,834 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | S Sale | 2024-01-04 | 2024-01-08 | 721 | $2.94 | $2.1K | 169,938 | SEC↗ |
| Umstead John W. V | Chief Financial Officer | S Sale | 2024-01-04 | 2024-01-08 | 111 | $2.94 | $326 | 130,443 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | A Award deriv | 2024-01-03 | 2024-01-08 | 74,500 | — | $0 | 74,500 | SEC↗ |
| Avagliano Mark | Chief Business Officer | A Award deriv | 2024-01-03 | 2024-01-08 | 89,400 | — | $0 | 89,400 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | A Award deriv | 2024-01-03 | 2024-01-08 | 201,300 | — | $0 | 201,300 | SEC↗ |
| Perry Andrew | Chief Commercial Officer | A Award deriv | 2024-01-03 | 2024-01-08 | 67,050 | — | $0 | 67,050 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | A Award deriv | 2024-01-03 | 2024-01-08 | 74,500 | — | $0 | 74,500 | SEC↗ |
| Thomas Monica R. | General Counsel | A Award deriv | 2024-01-03 | 2024-01-08 | 55,875 | — | $0 | 55,875 | SEC↗ |
| Umstead John W. V | Chief Financial Officer | A Award deriv | 2024-01-03 | 2024-01-08 | 74,500 | — | $0 | 74,500 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | A Award | 2024-01-03 | 2024-01-08 | 37,300 | — | $0 | 107,378 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | S Sale | 2024-01-03 | 2024-01-08 | 758 | $3.12 | $2.4K | 106,620 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | S Sale | 2024-01-03 | 2024-01-08 | 2,261 | $3.12 | $7.1K | 104,359 | SEC↗ |
| Avagliano Mark | Chief Business Officer | S Sale | 2024-01-03 | 2024-01-08 | 2,602 | $3.12 | $8.1K | 118,555 | SEC↗ |
| Avagliano Mark | Chief Business Officer | S Sale | 2024-01-03 | 2024-01-08 | 758 | $3.12 | $2.4K | 121,157 | SEC↗ |
| Avagliano Mark | Chief Business Officer | A Award | 2024-01-03 | 2024-01-08 | 44,760 | — | $0 | 121,915 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | S Sale | 2024-01-03 | 2024-01-08 | 9,094 | $3.12 | $28.4K | 489,594 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | A Award | 2024-01-03 | 2024-01-08 | 100,700 | — | $0 | 501,280 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | S Sale | 2024-01-03 | 2024-01-08 | 2,592 | $3.12 | $8.1K | 498,688 | SEC↗ |
| Perry Andrew | Chief Commercial Officer | S Sale | 2024-01-03 | 2024-01-08 | 379 | $3.12 | $1.2K | 89,136 | SEC↗ |
| Perry Andrew | Chief Commercial Officer | S Sale | 2024-01-03 | 2024-01-08 | 2,034 | $3.12 | $6.3K | 87,102 | SEC↗ |
| Perry Andrew | Chief Commercial Officer | A Award | 2024-01-03 | 2024-01-08 | 33,570 | — | $0 | 89,515 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | A Award | 2024-01-03 | 2024-01-08 | 37,300 | — | $0 | 173,678 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | S Sale | 2024-01-03 | 2024-01-08 | 758 | $3.12 | $2.4K | 172,920 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | S Sale | 2024-01-03 | 2024-01-08 | 2,261 | $3.12 | $7.1K | 170,659 | SEC↗ |
| Thomas Monica R. | General Counsel | A Award | 2024-01-03 | 2024-01-08 | 27,975 | — | $0 | 78,151 | SEC↗ |
| Umstead John W. V | Chief Financial Officer | A Award | 2024-01-03 | 2024-01-08 | 37,300 | — | $0 | 131,186 | SEC↗ |
| Umstead John W. V | Chief Financial Officer | S Sale | 2024-01-03 | 2024-01-08 | 253 | $3.12 | $789 | 130,933 | SEC↗ |
| Umstead John W. V | Chief Financial Officer | S Sale | 2024-01-03 | 2024-01-08 | 379 | $3.12 | $1.2K | 130,554 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | S Sale | 2024-01-02 | 2024-01-02 | 32,983 | $3.27 | $107.9K | 400,580 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | M Exercise deriv | 2023-12-11 | 2023-12-13 | 21,439 | — | $0 | 0 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | M Exercise deriv | 2023-12-11 | 2023-12-13 | 12,400 | — | $0 | 28,600 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | S Sale | 2023-12-11 | 2023-12-13 | 12,400 | $4.02 | $49.8K | 136,378 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | M Exercise | 2023-12-11 | 2023-12-13 | 12,400 | $0.30 | $3.7K | 148,778 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | S Sale | 2023-12-11 | 2023-12-13 | 21,439 | $3.06 | $65.6K | 136,378 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | M Exercise | 2023-12-11 | 2023-12-13 | 21,439 | $0.39 | $8.4K | 157,817 | SEC↗ |
| Velleca Mark A. | Director | M Exercise deriv | 2023-08-08 | 2023-08-10 | 57,286 | — | $0 | 0 | SEC↗ |
| Velleca Mark A. | Director | M Exercise deriv | 2023-08-08 | 2023-08-10 | 2,714 | — | $0 | 242,286 | SEC↗ |
| Velleca Mark A. | Director | S Sale | 2023-08-08 | 2023-08-10 | 2,714 | $2.02 | $5.5K | 116,000 | SEC↗ |
| Velleca Mark A. | Director | M Exercise | 2023-08-08 | 2023-08-10 | 2,714 | $0.30 | $814 | 118,714 | SEC↗ |
| Velleca Mark A. | Director | S Sale | 2023-08-08 | 2023-08-10 | 57,286 | $2.00 | $114.6K | 116,000 | SEC↗ |
| Velleca Mark A. | Director | M Exercise | 2023-08-08 | 2023-08-10 | 57,286 | $0.39 | $22.3K | 173,286 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | S Sale | 2023-07-05 | 2023-07-07 | 2,719 | $2.45 | $6.7K | 433,563 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | S Sale | 2023-07-05 | 2023-07-07 | 1,361 | $2.45 | $3.3K | 136,378 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | S Sale | 2023-07-05 | 2023-07-07 | 1,361 | $2.45 | $3.3K | 70,078 | SEC↗ |
| Perry Andrew | Chief Commercial Officer | S Sale | 2023-07-05 | 2023-07-07 | 355 | $2.45 | $870 | 55,945 | SEC↗ |
| Nicholson Garry A | Director | A Award deriv | 2023-06-15 | 2023-06-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Secor Alicia | Director | A Award deriv | 2023-06-15 | 2023-06-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Lee Jacks | Director | A Award deriv | 2023-06-15 | 2023-06-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MUIR GLENN P | Director | A Award deriv | 2023-06-15 | 2023-06-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Flowers Cynthia Louise | Director | A Award deriv | 2023-06-15 | 2023-06-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Sharpless Norman | Director | A Award deriv | 2023-06-15 | 2023-06-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Nicholson Garry A | Director | A Award | 2023-06-15 | 2023-06-16 | 10,000 | — | $0 | 24,389 | SEC↗ |
| Secor Alicia | Director | A Award | 2023-06-15 | 2023-06-16 | 10,000 | — | $0 | 20,000 | SEC↗ |
| Lee Jacks | Director | A Award | 2023-06-15 | 2023-06-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MUIR GLENN P | Director | A Award | 2023-06-15 | 2023-06-16 | 10,000 | — | $0 | 195,358 | SEC↗ |
| Flowers Cynthia Louise | Director | A Award | 2023-06-15 | 2023-06-16 | 10,000 | — | $0 | 25,889 | SEC↗ |
| Sharpless Norman | Director | A Award | 2023-06-15 | 2023-06-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Thomas Monica R. | General Counsel | A Award deriv | 2023-05-22 | 2023-05-24 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Thomas Monica R. | General Counsel | A Award | 2023-05-22 | 2023-05-24 | 50,000 | — | $0 | 50,176 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | A Award | 2023-05-10 | 2023-05-12 | 160,000 | — | $0 | 436,282 | SEC↗ |
| Perry Andrew | Chief Commercial Officer | A Award | 2023-05-10 | 2023-05-12 | 35,000 | — | $0 | 56,300 | SEC↗ |
| Umstead John V. | Chief Financial Officer | A Award | 2023-05-10 | 2023-05-12 | 35,000 | — | $0 | 93,886 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | A Award | 2023-05-10 | 2023-05-12 | 35,000 | — | $0 | 137,739 | SEC↗ |
| Avagliano Mark | Chief Business Officer | A Award | 2023-05-10 | 2023-05-12 | 35,000 | — | $0 | 77,155 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | A Award | 2023-05-10 | 2023-05-12 | 35,000 | — | $0 | 71,439 | SEC↗ |
| Umstead John V. | Chief Financial Officer | A Award deriv | 2023-03-15 | 2023-03-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Umstead John V. | Chief Financial Officer | A Award | 2023-03-15 | 2023-03-17 | 50,000 | — | $0 | 58,886 | SEC↗ |
| Hanson James S. | General Counsel | S Sale | 2023-01-05 | 2023-01-05 | 729 | $5.41 | $3.9K | 41,087 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | S Sale | 2023-01-05 | 2023-01-05 | 729 | $5.41 | $3.9K | 102,739 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | S Sale | 2023-01-05 | 2023-01-05 | 729 | $5.41 | $3.9K | 36,439 | SEC↗ |
| Moses Jennifer K. | CFO | S Sale | 2023-01-05 | 2023-01-05 | 729 | $5.41 | $3.9K | 57,820 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | S Sale | 2023-01-04 | 2023-01-05 | 5,607 | $5.58 | $31.3K | 276,282 | SEC↗ |
| Hanson James S. | General Counsel | S Sale | 2023-01-04 | 2023-01-05 | 1,639 | $5.58 | $9.1K | 41,816 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | S Sale | 2023-01-04 | 2023-01-05 | 1,639 | $5.58 | $9.1K | 103,468 | SEC↗ |
| Perry Andrew | Chief Commercial Officer | S Sale | 2023-01-04 | 2023-01-05 | 820 | $5.58 | $4.6K | 21,300 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | S Sale | 2023-01-04 | 2023-01-05 | 1,639 | $5.58 | $9.1K | 37,168 | SEC↗ |
| Moses Jennifer K. | CFO | S Sale | 2023-01-04 | 2023-01-05 | 1,639 | $5.58 | $9.1K | 58,549 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | A Award deriv | 2023-01-03 | 2023-01-05 | 161,300 | — | $0 | 161,300 | SEC↗ |
| Hanson James S. | General Counsel | A Award deriv | 2023-01-03 | 2023-01-05 | 35,700 | — | $0 | 35,700 | SEC↗ |
| Avagliano Mark | Chief Business Officer | A Award deriv | 2023-01-03 | 2023-01-05 | 41,100 | — | $0 | 41,100 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | A Award deriv | 2023-01-03 | 2023-01-05 | 35,700 | — | $0 | 35,700 | SEC↗ |
| Perry Andrew | Chief Commercial Officer | A Award deriv | 2023-01-03 | 2023-01-05 | 32,100 | — | $0 | 32,100 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | A Award deriv | 2023-01-03 | 2023-01-05 | 35,700 | — | $0 | 35,700 | SEC↗ |
| Moses Jennifer K. | CFO | A Award deriv | 2023-01-03 | 2023-01-05 | 44,600 | — | $0 | 44,600 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | S Sale | 2023-01-03 | 2023-01-05 | 32,019 | $5.85 | $187.3K | 281,889 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | A Award | 2023-01-03 | 2023-01-05 | 80,700 | — | $0 | 313,908 | SEC↗ |
| Hanson James S. | General Counsel | A Award | 2023-01-03 | 2023-01-05 | 17,900 | — | $0 | 43,455 | SEC↗ |
| Avagliano Mark | Chief Business Officer | A Award | 2023-01-03 | 2023-01-05 | 20,600 | — | $0 | 42,155 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | A Award | 2023-01-03 | 2023-01-05 | 17,900 | — | $0 | 105,107 | SEC↗ |
| Perry Andrew | Chief Commercial Officer | A Award | 2023-01-03 | 2023-01-05 | 16,100 | — | $0 | 22,120 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | A Award | 2023-01-03 | 2023-01-05 | 17,900 | — | $0 | 38,807 | SEC↗ |
| Moses Jennifer K. | CFO | A Award | 2023-01-03 | 2023-01-05 | 22,300 | — | $0 | 60,188 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | M Exercise deriv | 2022-12-15 | 2022-12-16 | 14,000 | — | $0 | 41,000 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | M Exercise | 2022-12-15 | 2022-12-16 | 14,000 | $0.30 | $4.2K | 87,207 | SEC↗ |
| Velleca Mark A. | Director | M Exercise deriv | 2022-10-18 | 2022-10-20 | 15,000 | — | $0 | 57,286 | SEC↗ |
| Velleca Mark A. | Director | M Exercise | 2022-10-18 | 2022-10-20 | 15,000 | $0.39 | $5.8K | 131,000 | SEC↗ |
| Velleca Mark A. | Director | S Sale | 2022-10-18 | 2022-10-20 | 15,000 | $11.70 | $175.5K | 116,000 | SEC↗ |
| Velleca Mark A. | Director | M Exercise deriv | 2022-09-20 | 2022-09-22 | 20,000 | — | $0 | 72,286 | SEC↗ |
| Velleca Mark A. | Director | S Sale | 2022-09-20 | 2022-09-22 | 20,000 | $13.50 | $270.0K | 116,000 | SEC↗ |
| Velleca Mark A. | Director | M Exercise | 2022-09-20 | 2022-09-22 | 20,000 | $0.39 | $7.8K | 136,000 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | M Exercise deriv | 2022-09-13 | 2022-09-16 | 18,000 | — | $0 | 21,439 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | M Exercise | 2022-09-13 | 2022-09-16 | 18,000 | $0.39 | $7.0K | 91,207 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | S Sale | 2022-09-13 | 2022-09-16 | 18,000 | $15.71 | $282.8K | 73,207 | SEC↗ |
| Velleca Mark A. | Director | M Exercise deriv | 2022-08-16 | 2022-08-18 | 80,000 | — | $0 | 92,286 | SEC↗ |
| Velleca Mark A. | Director | M Exercise | 2022-08-16 | 2022-08-18 | 80,000 | $0.39 | $31.2K | 196,000 | SEC↗ |
| Velleca Mark A. | Director | S Sale | 2022-08-16 | 2022-08-18 | 80,000 | $12.64 | $1.01M | 116,000 | SEC↗ |
| Sharpless Norman | Director | A Award deriv | 2022-08-04 | 2022-08-05 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | S Sale | 2022-07-05 | 2022-07-06 | 648 | $5.17 | $3.4K | 73,207 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | S Sale | 2022-07-05 | 2022-07-06 | 648 | $5.17 | $3.4K | 20,907 | SEC↗ |
| Lee Jacks | Director | A Award deriv | 2022-06-27 | 2022-06-29 | 60,000 | — | $0 | 60,000 | SEC↗ |
| MUIR GLENN P | Director | A Award deriv | 2022-06-23 | 2022-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Flowers Cynthia Louise | Director | A Award deriv | 2022-06-23 | 2022-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Deese Willie A | Director | A Award deriv | 2022-06-23 | 2022-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Nicholson Garry A | Director | A Award deriv | 2022-06-23 | 2022-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Secor Alicia | Director | A Award deriv | 2022-06-23 | 2022-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MUIR GLENN P | Director | A Award | 2022-06-23 | 2022-06-24 | 10,000 | — | $0 | 185,358 | SEC↗ |
| Flowers Cynthia Louise | Director | A Award | 2022-06-23 | 2022-06-24 | 10,000 | — | $0 | 15,889 | SEC↗ |
| Deese Willie A | Director | A Award | 2022-06-23 | 2022-06-24 | 10,000 | — | $0 | 14,389 | SEC↗ |
| Nicholson Garry A | Director | A Award | 2022-06-23 | 2022-06-24 | 10,000 | — | $0 | 14,389 | SEC↗ |
| Secor Alicia | Director | A Award | 2022-06-23 | 2022-06-24 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Velleca Mark A. | Director | M Exercise deriv | 2022-02-07 | 2022-02-08 | 15,000 | — | $0 | 172,286 | SEC↗ |
| Velleca Mark A. | Director | M Exercise | 2022-02-07 | 2022-02-08 | 15,000 | $0.39 | $5.8K | 116,000 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | M Exercise deriv | 2022-02-01 | 2022-02-02 | 10,000 | — | $0 | 55,000 | SEC↗ |
| Moses Jennifer K. | CFO | M Exercise deriv | 2022-02-01 | 2022-02-02 | 333 | — | $0 | 0 | SEC↗ |
| Moses Jennifer K. | CFO | M Exercise deriv | 2022-02-01 | 2022-02-02 | 2,000 | — | $0 | 58,000 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | M Exercise | 2022-02-01 | 2022-02-02 | 10,000 | $0.30 | $3.0K | 73,855 | SEC↗ |
| Moses Jennifer K. | CFO | M Exercise | 2022-02-01 | 2022-02-02 | 2,000 | $4.17 | $8.3K | 37,888 | SEC↗ |
| Moses Jennifer K. | CFO | M Exercise | 2022-02-01 | 2022-02-02 | 333 | $3.72 | $1.2K | 35,888 | SEC↗ |
| Avagliano Mark | Chief Business Officer | S Sale | 2022-01-05 | 2022-01-05 | 1,445 | $10.61 | $15.3K | 21,555 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | S Sale | 2022-01-05 | 2022-01-05 | 1,445 | $10.61 | $15.3K | 63,855 | SEC↗ |
| Moses Jennifer K. | CFO | S Sale | 2022-01-05 | 2022-01-05 | 1,445 | $10.61 | $15.3K | 35,555 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | S Sale | 2022-01-05 | 2022-01-05 | 1,445 | $10.61 | $15.3K | 21,555 | SEC↗ |
| Hanson James S. | General Counsel | S Sale | 2022-01-05 | 2022-01-05 | 1,445 | $10.61 | $15.3K | 25,555 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | A Award deriv | 2022-01-03 | 2022-01-05 | 204,000 | — | $0 | 204,000 | SEC↗ |
| Avagliano Mark | Chief Business Officer | A Award deriv | 2022-01-03 | 2022-01-05 | 53,000 | — | $0 | 53,000 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | A Award deriv | 2022-01-03 | 2022-01-05 | 53,000 | — | $0 | 53,000 | SEC↗ |
| Moses Jennifer K. | CFO | A Award deriv | 2022-01-03 | 2022-01-05 | 53,000 | — | $0 | 53,000 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | A Award deriv | 2022-01-03 | 2022-01-05 | 53,000 | — | $0 | 53,000 | SEC↗ |
| Perry Andrew | Chief Commercial Officer | A Award deriv | 2022-01-03 | 2022-01-05 | 26,500 | — | $0 | 26,500 | SEC↗ |
| Hanson James S. | General Counsel | A Award deriv | 2022-01-03 | 2022-01-05 | 53,000 | — | $0 | 53,000 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | S Sale | 2022-01-03 | 2022-01-05 | 34,125 | $10.41 | $355.2K | 233,208 | SEC↗ |
| Bailey John E. (Jack) Jr. | President and CEO | A Award | 2022-01-03 | 2022-01-05 | 46,000 | — | $0 | 267,333 | SEC↗ |
| Avagliano Mark | Chief Business Officer | A Award | 2022-01-03 | 2022-01-05 | 12,000 | — | $0 | 23,000 | SEC↗ |
| Malik Rajesh | Chief Medical Officer | A Award | 2022-01-03 | 2022-01-05 | 12,000 | — | $0 | 65,300 | SEC↗ |
| Moses Jennifer K. | CFO | A Award | 2022-01-03 | 2022-01-05 | 12,000 | — | $0 | 37,000 | SEC↗ |
| MURDOCK TERRY L | Chief Operating Officer | A Award | 2022-01-03 | 2022-01-05 | 12,000 | — | $0 | 23,000 | SEC↗ |
| Perry Andrew | Chief Commercial Officer | A Award | 2022-01-03 | 2022-01-05 | 6,000 | — | $0 | 6,020 | SEC↗ |
| Hanson James S. | General Counsel | A Award | 2022-01-03 | 2022-01-05 | 12,000 | — | $0 | 27,000 | SEC↗ |
| Velleca Mark A. | Director | M Exercise deriv | 2021-11-09 | 2021-11-10 | 40,000 | — | $0 | 187,286 | SEC↗ |
| Velleca Mark A. | Director | M Exercise | 2021-11-09 | 2021-11-10 | 40,000 | $0.39 | $15.6K | 101,000 | SEC↗ |
| Perry Andrew | Chief Commercial Officer | A Award deriv | 2021-08-16 | 2021-08-17 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Velleca Mark A. | Director | M Exercise deriv | 2021-07-15 | 2021-07-15 | 10,000 | — | $0 | 227,286 | SEC↗ |
| Velleca Mark A. | Director | M Exercise | 2021-07-15 | 2021-07-15 | 10,000 | $0.39 | $3.9K | 71,000 | SEC↗ |
| Velleca Mark A. | Director | S Sale | 2021-07-15 | 2021-07-15 | 10,000 | $18.49 | $184.9K | 61,000 | SEC↗ |
| Velleca Mark A. | Director | M Exercise deriv | 2021-07-14 | 2021-07-15 | 10,000 | — | $0 | 237,286 | SEC↗ |
| Velleca Mark A. | Director | M Exercise | 2021-07-14 | 2021-07-15 | 10,000 | $0.39 | $3.9K | 71,000 | SEC↗ |
| Velleca Mark A. | Director | S Sale | 2021-07-14 | 2021-07-15 | 10,000 | $19.08 | $190.8K | 61,000 | SEC↗ |
| Velleca Mark A. | Director | M Exercise deriv | 2021-07-13 | 2021-07-15 | 10,000 | — | $0 | 247,286 | SEC↗ |
| Velleca Mark A. | Director | M Exercise | 2021-07-13 | 2021-07-15 | 10,000 | $0.39 | $3.9K | 71,000 | SEC↗ |
| Velleca Mark A. | Director | S Sale | 2021-07-13 | 2021-07-15 | 10,000 | $19.45 | $194.5K | 61,000 | SEC↗ |
| RUDNICK SETH | Director | M Exercise deriv | 2021-06-29 | 2021-06-30 | 2,031 | — | $0 | 11,859 | SEC↗ |
| RUDNICK SETH | Director | M Exercise deriv | 2021-06-29 | 2021-06-30 | 7,969 | — | $0 | 0 | SEC↗ |
| RUDNICK SETH | Director | M Exercise | 2021-06-29 | 2021-06-30 | 7,969 | $0.39 | $3.1K | 12,358 | SEC↗ |
| RUDNICK SETH | Director | S Sale | 2021-06-29 | 2021-06-30 | 10,000 | $22.35 | $223.5K | 4,389 | SEC↗ |
| RUDNICK SETH | Director | M Exercise | 2021-06-29 | 2021-06-30 | 2,031 | $0.30 | $609 | 14,389 | SEC↗ |
| Velleca Mark A. | Director | M Exercise deriv | 2021-06-17 | 2021-06-17 | 10,000 | — | $0 | 257,286 | SEC↗ |
| Deese Willie A | Director | A Award deriv | 2021-06-17 | 2021-06-21 | 19,620 | — | $0 | 19,620 | SEC↗ |
| Nicholson Garry A | Director | A Award deriv | 2021-06-17 | 2021-06-21 | 19,620 | — | $0 | 19,620 | SEC↗ |
| MUIR GLENN P | Director | A Award deriv | 2021-06-17 | 2021-06-21 | 19,620 | — | $0 | 19,620 | SEC↗ |
| RUDNICK SETH | Director | A Award deriv | 2021-06-17 | 2021-06-21 | 19,620 | — | $0 | 19,620 | SEC↗ |
| Schwalm Cynthia | Director | A Award deriv | 2021-06-17 | 2021-06-21 | 19,620 | — | $0 | 19,620 | SEC↗ |
| Secor Alicia | Director | A Award deriv | 2021-06-17 | 2021-06-21 | 52,320 | — | $0 | 52,320 | SEC↗ |
| Velleca Mark A. | Director | M Exercise | 2021-06-17 | 2021-06-17 | 10,000 | $0.39 | $3.9K | 71,000 | SEC↗ |
| Velleca Mark A. | Director | S Sale | 2021-06-17 | 2021-06-17 | 10,000 | $21.77 | $217.7K | 61,000 | SEC↗ |
| Deese Willie A | Director | A Award | 2021-06-17 | 2021-06-21 | 4,389 | — | $0 | 4,389 | SEC↗ |
| Nicholson Garry A | Director | A Award | 2021-06-17 | 2021-06-21 | 4,389 | — | $0 | 4,389 | SEC↗ |
| MUIR GLENN P | Director | A Award | 2021-06-17 | 2021-06-21 | 4,389 | — | $0 | 175,358 | SEC↗ |
| RUDNICK SETH | Director | A Award | 2021-06-17 | 2021-06-21 | 4,389 | — | $0 | 4,389 | SEC↗ |
| Schwalm Cynthia | Director | A Award | 2021-06-17 | 2021-06-21 | 4,389 | — | $0 | 5,889 | SEC↗ |
| Velleca Mark A. | Director | M Exercise deriv | 2021-06-16 | 2021-06-17 | 10,000 | — | $0 | 267,286 | SEC↗ |
| Velleca Mark A. | Director | S Sale | 2021-06-16 | 2021-06-17 | 10,000 | $21.74 | $217.4K | 61,000 | SEC↗ |
| Velleca Mark A. | Director | M Exercise | 2021-06-16 | 2021-06-17 | 10,000 | $0.39 | $3.9K | 71,000 | SEC↗ |
| Velleca Mark A. | Director | M Exercise deriv | 2021-06-15 | 2021-06-17 | 10,000 | — | $0 | 277,286 | SEC↗ |
| Velleca Mark A. | Director | M Exercise | 2021-06-15 | 2021-06-17 | 10,000 | $0.39 | $3.9K | 71,000 | SEC↗ |
| Velleca Mark A. | Director | S Sale | 2021-06-15 | 2021-06-17 | 10,000 | $22.39 | $223.9K | 61,000 | SEC↗ |
| Velleca Mark A. | Director | M Exercise deriv | 2021-05-25 | 2021-05-25 | 20,000 | — | $0 | 287,286 | SEC↗ |
| Velleca Mark A. | Director | M Exercise | 2021-05-25 | 2021-05-25 | 20,000 | $0.39 | $7.8K | 61,000 | SEC↗ |
| Velleca Mark A. | Director | M Exercise deriv | 2021-05-13 | 2021-05-13 | 10,000 | — | $0 | 307,286 | SEC↗ |
| Velleca Mark A. | Director | S Sale | 2021-05-13 | 2021-05-13 | 10,000 | $20.54 | $205.4K | 41,000 | SEC↗ |
| Velleca Mark A. | Director | M Exercise | 2021-05-13 | 2021-05-13 | 10,000 | $0.39 | $3.9K | 51,000 | SEC↗ |
| Velleca Mark A. | Director | M Exercise deriv | 2021-05-12 | 2021-05-13 | 10,000 | — | $0 | 317,286 | SEC↗ |
| Velleca Mark A. | Director | M Exercise | 2021-05-12 | 2021-05-13 | 10,000 | $0.39 | $3.9K | 51,000 | SEC↗ |
| Velleca Mark A. | Director | S Sale | 2021-05-12 | 2021-05-13 | 10,000 | $20.07 | $200.7K | 41,000 | SEC↗ |
| Velleca Mark A. | Director | M Exercise deriv | 2021-05-11 | 2021-05-13 | 10,000 | — | $0 | 327,286 | SEC↗ |
| Velleca Mark A. | Director | S Sale | 2021-05-11 | 2021-05-13 | 10,000 | $19.10 | $191.0K | 41,000 | SEC↗ |